MedWatch

Electronics firm presents long-awaited hearing solution

Following an approval from the US FDA in 2018, technology firm Bose is now launching its new low-cost, self-tuning hearing aid which works in the same way as the upcoming OTC devices in the US.

Photo: Bose / PR

US residents suffering form mild to moderate hearing loss will now be able to purchase hearing aids without seeing an audiologist or healthcare professional for tuning and programming.

Following years of waiting, electronics and audio equipment company Bose Corporations has lifted the veil on the firm's new hearing aid Bose Soundcontrol, which was approved – as the first of its kind – back in October 2018 by the US Food and Drud Administration (FDA).

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs